At a time when India is grappling with second wave of coronavirus, the union government on Friday announced manifold increase in production capacity of Covaxin in the coming months. The production capacity is expected to reach nearly 100 million doses per month by September 2021 from the existing 10 million doses. "Government of India is providing financial support as grant to vaccine manufacturing facilities for enhanced production capacities. The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021 i.e increasing the production from 10 million vaccine doses in April, 2021 to 60-70 million vaccine doses/month in July–August. It is expected to reach nearly 100 million doses per month by September 2021," said Ministry of Science & Technology in a statement.